Loading…

Efficacy and Safety of Use of the Fasting Algorithm for Singaporeans With Type 2 Diabetes (FAST) During Ramadan: A Prospective, Multicenter, Randomized Controlled Trial

We aimed to evaluate the efficacy and safety of use of the Fasting Algorithm for Singaporeans with Type 2 Diabetes (FAST) during Ramadan. We performed a prospective, multicenter, randomized controlled trial. The inclusion criteria were age ≥21 years, baseline glycated hemoglobin (HbA ) level ≤9.5%,...

Full description

Saved in:
Bibliographic Details
Published in:Annals of family medicine 2020-03, Vol.18 (2), p.139-147
Main Authors: Lum, Zheng Kang, Khoo, Zi Rui, Toh, Wei Yann See, Kamaldeen, Shaikh Abdul Kader, Shakoor, Abdul, Tsou, Keith Yu Kei, Chew, Daniel Ek Kwang, Dalan, Rinkoo, Kwek, Sing Cheer, Othman, Noorani, Lian, Joyce Xia, Bte Sunari, Raden Nurheryany, Lee, Joyce Yu-Chia
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We aimed to evaluate the efficacy and safety of use of the Fasting Algorithm for Singaporeans with Type 2 Diabetes (FAST) during Ramadan. We performed a prospective, multicenter, randomized controlled trial. The inclusion criteria were age ≥21 years, baseline glycated hemoglobin (HbA ) level ≤9.5%, and intention to fast for ≥10 days during Ramadan. Exclusion criteria included baseline estimated glomerular filtration rate
ISSN:1544-1709
1544-1717
DOI:10.1370/afm.2500